Cellectis (NASDAQ:CLLS – Get Rating) and ZIVO Bioscience (NASDAQ:ZIVO – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Earnings & Valuation This table compares Cellectis and ZIVO Bioscience’s […]
Cellectis S.A. (NASDAQ:CLLS – Get Rating) was the target of a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 316,700 shares, a decrease of 12.9% from the April 15th total of 363,800 shares. Based on an average daily volume of 85,100 shares, the days-to-cover […]
Cellectis (NASDAQ:CLLS – Get Rating) is scheduled to release its earnings data after the market closes on Thursday, May 4th. Analysts expect Cellectis to post earnings of ($0.30) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Cellectis Stock Down 5.6 % […]
Cellectis (NASDAQ:CLLS – Get Rating) is scheduled to announce its earnings results after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.30) per share for the quarter. Cellectis Stock Up 1.6 % CLLS opened at $1.94 on Friday. The stock has a market capitalization of $107.83 million, a […]
Shares of Cellectis S.A. (NASDAQ:CLLS – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eight research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have assigned a buy recommendation to the […]